Arachidonic acid metabolites in pathogenic yeasts

Area of Science:

• Biochemistry
• Mycology
• Eukaryotic Biology

Background:

• Arachidonic acid metabolites are well-studied in mammals but less understood in lower eukaryotes like fungi.
• Knowledge gaps exist regarding fungal oxylipin production pathways and their biological functions.

Purpose of the Study:

• To review the discovery of oxylipins, specifically arachidonic acid-derived eicosanoids, in yeasts since the 1990s.
• To summarize current knowledge on metabolic pathways and proteins involved in oxylipin production in pathogenic yeasts.
• To discuss the potential roles of these oxylipins in fungal and yeast biology, including pathogenesis.

Main Methods:

• Literature review focusing on oxylipins in yeasts.
• Analysis of studies on arachidonic acid metabolism in fungi.
• Synthesis of information on eicosanoids like prostaglandin F2α and E2 in yeast.

Main Results:

• Oxylipins, including 3-hydroxy eicosatetraenoic acid, prostaglandin F2α, and prostaglandin E2, have been identified in yeasts.
• Initial insights into specific metabolic pathways and proteins responsible for oxylipin synthesis in pathogenic yeasts are emerging.
• These compounds are implicated in various aspects of fungal and yeast biology.

Conclusions:

• Oxylipins represent an understudied area in fungal and yeast biology with significant implications.
• Further research into fungal oxylipin pathways and functions is crucial for understanding yeast biology and pathogenesis.
• Understanding these metabolites may offer new avenues for therapeutic interventions against pathogenic yeasts.